Acurx Pharmaceuticals, Inc. (ACXP)
4.30
+0.06
(+1.42%)
USD |
NASDAQ |
Dec 10, 15:52
Acurx Pharmaceuticals Free Cash Flow: -7.854M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Synergy CHC Corp. | -6.635M |
| Sharps Technology, Inc. | -17.00M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.881M |
| Cash from Financing (Quarterly) | 1.724M |
| Free Cash Flow Per Share (Quarterly) | -1.157 |
| Free Cash Flow to Equity (Quarterly) | -1.881M |
| Free Cash Flow to Firm (Quarterly) | -1.881M |
| Free Cash Flow Yield | -30.82% |